课题基金 / 基金详情

FY23. TO5. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 01/18/2022 - 04/16/2024. NIDA REF. NO. N01DA-19-8947.

FY23. TO5. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 01/18/2022 - 04/16/2024. NIDA REF. NO. N01DA-19-8947.
23 财年。
批准号：
10948307
负责人：
DANIEL MOLINA
金额：
$0.9万
依托单位：
TECHNICAL RESOURCES INTERNATIONAL, INC.
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
项目状态：
已结题
起止时间：
2022-01-18 至 2024-04-16
来源：
https://reporter.nih.gov/project-details/10948307
关键词：
FY23.TO5.NIDAPHARMACOKINETICANALYSIS

项目摘要

项目成果

DANIEL MOLINA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Substance Misuse The purpose of this task order is to provide clinical support for a multicenter Phase 3 clinical trial of an investigational combination for the treatment of methamphetamine use disorder.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE I COCAINE DRUG INTERACTION STUDY. TO6. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 08/10/2023 - 02/09/2025. NIDA REF. NO. N01DA-19-8947.
NIAID CLINICAL DATA AND SAFETY MANAGEMENT CENTER (CDSMC)
DATA COORDINATING CENTER FOR SPROUTS AGES 6- AND 7- YEARS ASSESSMENTS AND STUDY CLOSEOUT
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE OTHER SUPPORT SERVICES TO NIDA AS PART OF CONTRACT PERFORMANCE. SPECIFICALLY, THIS TO INVOLVES WORK DESCRIBED IN TASK G. THE SCOPE OF THIS TASK IS FOR SEV
海外基金